FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3133588053> ?p ?o ?g. }

• W3133588053 endingPage "1009" @default.
• W3133588053 startingPage "1003" @default.
• W3133588053 abstract "Background: Mannitol is a mucoactive hyperosmotic agent used as add-on therapy in patients with cystic fibrosis (CF), administered twice-daily (BID) via a small, portable, breath-actuated dry-powder inhaler. This study was conducted to provide confirmatory evidence of mannitol's efficacy and safety in adults.Methods: This multicenter, double-blind, randomized, parallel-group, controlled clinical trial recruited adults (aged ≥18 years) with CF, and forced expiratory volume in 1 second (FEV1) 40–90% predicted. Subjects received either mannitol 400 mg or mannitol 50 mg (control), BID via dry-powder inhaler for 26 weeks. Primary endpoint: FEV1 averaged over the 26-week treatment period.Results: Of 423 subjects randomized (209 or 214 receiving mannitol 400 mg BID or control, respectively), 373 (88.2%) completed the study, with a similar proportion completing in the two groups. For FEV1 averaged over 26 weeks, mannitol 400 mg BID was statistically superior to control (adjusted mean difference 54 mL [95% CI 8, 100 mL]; p = 0.020). This was supported by sensitivity analyses of the primary endpoint, and by observed improvements in secondary pulmonary function endpoints (eg, absolute adjusted mean difference in percent predicted FEV1 averaged over 26 weeks 1.21% [0.07%, 2.36%]; p = 0.037). Adverse events were mainly mild or moderate in severity, with treatment-related adverse events in 15.5 and 12.2% of subjects receiving mannitol 400 mg BID and control, respectively.Conclusions: In adults with CF, mannitol 400 mg BID inhaled as a dry-powder statistically significantly improved lung function (FEV1) compared with control, with this improvement supported by sensitivity analyses and secondary pulmonary function endpoints. Mannitol had a good overall safety and tolerability profile. ClinicalTrials.gov: NCT02134353." @default.
• W3133588053 created "2021-03-15" @default.
• W3133588053 creator A5004271838 @default.
• W3133588053 creator A5005915390 @default.
• W3133588053 creator A5027049859 @default.
• W3133588053 creator A5029091133 @default.
• W3133588053 creator A5082232720 @default.
• W3133588053 creator A5082827731 @default.
• W3133588053 creator A5087246234 @default.
• W3133588053 date "2021-11-01" @default.
• W3133588053 modified "2023-10-17" @default.
• W3133588053 title "Efficacy and safety of inhaled dry-powder mannitol in adults with cystic fibrosis: An international, randomized controlled study" @default.
• W3133588053 cites W1607065932 @default.
• W3133588053 cites W1976264709 @default.
• W3133588053 cites W2018417584 @default.
• W3133588053 cites W2040975079 @default.
• W3133588053 cites W2047080603 @default.
• W3133588053 cites W2047582511 @default.
• W3133588053 cites W2048129161 @default.
• W3133588053 cites W2079925652 @default.
• W3133588053 cites W2096013141 @default.
• W3133588053 cites W2104379296 @default.
• W3133588053 cites W2108676410 @default.
• W3133588053 cites W2124135806 @default.
• W3133588053 cites W2124798883 @default.
• W3133588053 cites W2131236190 @default.
• W3133588053 cites W2134260485 @default.
• W3133588053 cites W2144947606 @default.
• W3133588053 cites W2145454135 @default.
• W3133588053 cites W2146890489 @default.
• W3133588053 cites W2152715766 @default.
• W3133588053 cites W2166059037 @default.
• W3133588053 cites W2168454304 @default.
• W3133588053 cites W2253808859 @default.
• W3133588053 cites W2333398204 @default.
• W3133588053 cites W2604428838 @default.
• W3133588053 cites W2782069977 @default.
• W3133588053 cites W2906834688 @default.
• W3133588053 cites W2947745877 @default.
• W3133588053 cites W4232966707 @default.
• W3133588053 doi "https://doi.org/10.1016/j.jcf.2021.02.011" @default.
• W3133588053 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33715994" @default.
• W3133588053 hasPublicationYear "2021" @default.
• W3133588053 type Work @default.
• W3133588053 sameAs 3133588053 @default.
• W3133588053 citedByCount "6" @default.
• W3133588053 countsByYear W31335880532021 @default.
• W3133588053 countsByYear W31335880532022 @default.
• W3133588053 countsByYear W31335880532023 @default.
• W3133588053 crossrefType "journal-article" @default.
• W3133588053 hasAuthorship W3133588053A5004271838 @default.
• W3133588053 hasAuthorship W3133588053A5005915390 @default.
• W3133588053 hasAuthorship W3133588053A5027049859 @default.
• W3133588053 hasAuthorship W3133588053A5029091133 @default.
• W3133588053 hasAuthorship W3133588053A5082232720 @default.
• W3133588053 hasAuthorship W3133588053A5082827731 @default.
• W3133588053 hasAuthorship W3133588053A5087246234 @default.
• W3133588053 hasBestOaLocation W31335880531 @default.
• W3133588053 hasConcept C126322002 @default.
• W3133588053 hasConcept C168563851 @default.
• W3133588053 hasConcept C178790620 @default.
• W3133588053 hasConcept C185592680 @default.
• W3133588053 hasConcept C197934379 @default.
• W3133588053 hasConcept C203092338 @default.
• W3133588053 hasConcept C2776042228 @default.
• W3133588053 hasConcept C2776938444 @default.
• W3133588053 hasConcept C2777419714 @default.
• W3133588053 hasConcept C2778445172 @default.
• W3133588053 hasConcept C2780261241 @default.
• W3133588053 hasConcept C42219234 @default.
• W3133588053 hasConcept C71924100 @default.
• W3133588053 hasConcept C75603125 @default.
• W3133588053 hasConcept C90924648 @default.
• W3133588053 hasConceptScore W3133588053C126322002 @default.
• W3133588053 hasConceptScore W3133588053C168563851 @default.
• W3133588053 hasConceptScore W3133588053C178790620 @default.
• W3133588053 hasConceptScore W3133588053C185592680 @default.
• W3133588053 hasConceptScore W3133588053C197934379 @default.
• W3133588053 hasConceptScore W3133588053C203092338 @default.
• W3133588053 hasConceptScore W3133588053C2776042228 @default.
• W3133588053 hasConceptScore W3133588053C2776938444 @default.
• W3133588053 hasConceptScore W3133588053C2777419714 @default.
• W3133588053 hasConceptScore W3133588053C2778445172 @default.
• W3133588053 hasConceptScore W3133588053C2780261241 @default.
• W3133588053 hasConceptScore W3133588053C42219234 @default.
• W3133588053 hasConceptScore W3133588053C71924100 @default.
• W3133588053 hasConceptScore W3133588053C75603125 @default.
• W3133588053 hasConceptScore W3133588053C90924648 @default.
• W3133588053 hasFunder F4320309888 @default.
• W3133588053 hasIssue "6" @default.
• W3133588053 hasLocation W31335880531 @default.
• W3133588053 hasLocation W31335880532 @default.
• W3133588053 hasOpenAccess W3133588053 @default.
• W3133588053 hasPrimaryLocation W31335880531 @default.
• W3133588053 hasRelatedWork W1970607021 @default.
• W3133588053 hasRelatedWork W2134056832 @default.
• W3133588053 hasRelatedWork W2158554969 @default.
• W3133588053 hasRelatedWork W2283700037 @default.

• next